---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-26-004068"
form_type: "8-K"
ticker: "INBS"
cik: "0001725430"
company_name: "INTELLIGENT BIO SOLUTIONS INC."
filed_at: "2026-01-28T23:59:59+00:00"
generated_at: "2026-05-16T07:03:12.188049+00:00"
event_type: "regulatory"
sentiment: "positive"
materiality_score: 0.65
calibrated_materiality_score: 0.65
confidence: "high"
source: SEC EDGAR
---

# Intelligent Bio Solutions starts clinical studies for FDA 510(k) submission to detect codeine via fingerprint

## Summary
- Partnered with Cliantha Research for a study in 40 adults to establish codeine detection cut-off levels.
- Study uses Intelligent Fingerprinting Drug Screening System with DSR-Plus reader; full data analysis expected by end of March 2026.
- Data will support FDA 510(k) submission and planned commercial launch into the multi-billion-dollar U.S. drug screening market.
- Company notes over 500,000 tests already sold outside the U.S.; targeting workplace, clinical, and law enforcement segments.

## SEC filing metadata
- accession: 0001493152-26-004068
- form_type: 8-K
- ticker: INBS
- cik: 0001725430
- company_name: INTELLIGENT BIO SOLUTIONS INC.
- filed_at: 2026-01-28T23:59:59+00:00
- event_type: regulatory
- sentiment: positive
- materiality_score: 0.65
- calibrated_materiality_score: 0.65
- confidence: high
- sec_items: 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1725430/000149315226004068/0001493152-26-004068-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1725430/000149315226004068/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-26-004068
- JSON: https://secwatch.observer/filing/0001493152-26-004068.json
- Plain text: https://secwatch.observer/filing/0001493152-26-004068.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.